Cha Women's Medical Research Institute Seoul Station and the Korean Association of New York and LA signed a business agreement to promote infertility treatment
Oct 02, 2025
Cha Women's Medical Institute Seoul Station (Director Yoon Tae-ki) signed a series of business agreements with the Korean American Association of Greater New York: KAAGNY and the Korean American Federation of Los Angeles (KAFLA) to revitalize infertility treatment and establish a global infertility network.
The MOU with the New York Korean Association in September was attended by Lee Myung-seok, chairman of the New York Korean Association, Yoon Tae-ki, director of the Cha Women's Medical Research Institute, and Shin Se-chan, managing director. Through the MOU, the two organizations agreed to cooperate in strengthening the global infertility network, including improving and revitalizing infertility treatment services for overseas Koreans. The agreement, which followed the agreement with the Korean Association of Los Angeles in June, is said to have been an important turning point in informing the American region of the competitiveness of K-medicine. In particular, it is expected to increase practical medical access by laying the foundation for providing high-quality infertility treatment services owned by Cha Hospital to Korean Americans such as New York and LA. In addition, it will serve as a strategic foothold for domestic medical institutions to expand their global expansion as well as revitalizing the attraction of foreign patients.
"Based on the cooperative system of the two organizations, we expect to be able to strengthen the competitiveness of infertility centers and go one step further in creating a world-class medical environment," said Yoon Tae-ki.
Lee Myung-seok, chairman of the New York Korean Association, said, `Through an agreement with the Cha Women's Medical Research Institute, we will aim to strengthen a global medical network that encompasses Koreans abroad and New York's mainstream society.'
Robert Ahn, chairman of the Korean Association of Los Angeles, who signed the agreement in June, also said, `It is very meaningful to cooperate with Seoul Station of Cha Women's Medical Research Institute with abundant experience and the best capabilities in the field of infertility medicine.''We will expand the global medical cooperation network together with this agreement and make efforts to promote the importance of infertility treatment at home and abroad.'
The agreement was pushed forward after Cha Shin Se-chan, managing director of Seoul Station at the Women's Medical Research Institute, was appointed as an international education clinic by the Korean Association of New York.
Cha Women's Medical Research Institute Seoul Station, which opened in 2016 as Asia's largest infertility center, has world-class medical staff and research institutes. In particular, obstetrics and gynecology, urology, and internal medicine are provided at the same time, so the cause of infertility is accurately identified through a systematic treatment system, and individual customized treatment is performed to increase the success rate of pregnancy. Cha Women's Medical Research Institute Seoul Station is striving not only for infertility treatment but also for the development of global infertility treatment medicine, and is constantly promoting development to establish and improve a multidisciplinary network.
The MOU with the New York Korean Association in September was attended by Lee Myung-seok, chairman of the New York Korean Association, Yoon Tae-ki, director of the Cha Women's Medical Research Institute, and Shin Se-chan, managing director. Through the MOU, the two organizations agreed to cooperate in strengthening the global infertility network, including improving and revitalizing infertility treatment services for overseas Koreans. The agreement, which followed the agreement with the Korean Association of Los Angeles in June, is said to have been an important turning point in informing the American region of the competitiveness of K-medicine. In particular, it is expected to increase practical medical access by laying the foundation for providing high-quality infertility treatment services owned by Cha Hospital to Korean Americans such as New York and LA. In addition, it will serve as a strategic foothold for domestic medical institutions to expand their global expansion as well as revitalizing the attraction of foreign patients.
"Based on the cooperative system of the two organizations, we expect to be able to strengthen the competitiveness of infertility centers and go one step further in creating a world-class medical environment," said Yoon Tae-ki.
Lee Myung-seok, chairman of the New York Korean Association, said, `Through an agreement with the Cha Women's Medical Research Institute, we will aim to strengthen a global medical network that encompasses Koreans abroad and New York's mainstream society.'
Robert Ahn, chairman of the Korean Association of Los Angeles, who signed the agreement in June, also said, `It is very meaningful to cooperate with Seoul Station of Cha Women's Medical Research Institute with abundant experience and the best capabilities in the field of infertility medicine.''We will expand the global medical cooperation network together with this agreement and make efforts to promote the importance of infertility treatment at home and abroad.'
The agreement was pushed forward after Cha Shin Se-chan, managing director of Seoul Station at the Women's Medical Research Institute, was appointed as an international education clinic by the Korean Association of New York.
Cha Women's Medical Research Institute Seoul Station, which opened in 2016 as Asia's largest infertility center, has world-class medical staff and research institutes. In particular, obstetrics and gynecology, urology, and internal medicine are provided at the same time, so the cause of infertility is accurately identified through a systematic treatment system, and individual customized treatment is performed to increase the success rate of pregnancy. Cha Women's Medical Research Institute Seoul Station is striving not only for infertility treatment but also for the development of global infertility treatment medicine, and is constantly promoting development to establish and improve a multidisciplinary network.
|
This article was translated by Naver AI translator.
